EVALUATION AND IMPROVEMENT OF NEW PRODUCT DEVELOPMENT AT PT OTTO PHARMACEUTICAL INDUSTRIES

• Main Author: PRAMUTADI (NIM : 29108001); Pembimbing Akdemik: Dr. Mursyid Hasan Basri, S.T., M.T., FEBY
• Format: Theses
• Language: Indonesia
• Online Access: https://digilib.itb.ac.id/gdl/view/15661
• Institution: Institut Teknologi Bandung

PT Otto Pharmaceutical Industries (PT OPI) is one of the oldest pharmaceutical company in Indonesia which has core business producing and marketing ethical drugs (to be prescribed by physicians) besides generics and OTC (over the counter) drugs. The company develops new drug <br /> <br /> <br /> products in order to compete with competitors and to maintain product life cycle and eventually to maintain current market share. During development process, the company is exposed to the risk of failure or delayed product launching caused by external and internal factors. <br /> <br /> <br /> This research investigates the root cause of product launching failure and delay as well as how to solve the identified problem. Methodologies used in this research are identification of problems and situation analysis through interview, examination, business process mapping and data collection. Then the research identifies root cause of problem and how to manage it by proposing several solutions with its analysis. The implementation plan, action plan, and human reseources plan were made for each best solution. <br /> <br /> <br /> The analysis shows several root cause in product launching failure and delay. Those are lack of competence in patent analysis, economic condition, new competitors, exchange rate, raw material supplier, inadequate human resource in BPOM and the company, insufficient capital, and packaging printing verification. <br /> <br /> <br /> Four roots cause i.e. lack of competence in patent analysis, raw material supplier, inadequate human resource in BPOM, and packaging printing verification were evaluated. The best solution for each root cause was proposed. The best solution offered are creating "selfassessment" document by Ditjen HKI, contacting raw material producers directly with database aid, increasing the quality of registration dossier by creating document checklist, and involving registration department in packaging artwork verification. <br /> <br /> <br /> To implement those solutions, the company will need additional cost of 136 million rupiah per year. However, the benefits could be achieved are time saving for developing new product for 9 months, cost saving potency from raw material USD 27,000 and cost saving potency because of mistakes in patent analysis and incorrect packaging printing. <br />